EM1906F "Acute-on-Chronic Liver Failure" (IM GR-060719)
The purpose of this lecture will be to define ACLF, describe the expected outcome after development, and educate the audience on how to decrease its incidence.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Define ACLF
- Describe the prognosis of a patient with ACLF
- Describe why patients with cirrhosis are at risk for ACLF
- Delineate ways to prevent ACLF
Jacqueline G. O’Leary, M.D., M.P.H.
Chief of Hepatology, Dallas VA
Associate Professor, Department of Internal Medicine
Division of Digestive & Liver Diseases
Dr. Jacqueline O’Leary began her pursuit of research as an undergraduate at Stanford University investigating drug development, continued at UCSF where she received an MD with thesis for work in cellular and molecular biology. Following her internal medicine residency at UT Southwestern, Dr. O’Leary did a GI fellowship and Transplant Hepatology fellowship at Massachusetts General Hospital. Her post-doctoral research there at Harvard focused on basic science immunology. Afterward, she completed a Master’s in Public Health from the Harvard School of Public Health in Clinical Effectiveness. These accomplishments make her uniquely poised to translate research findings into clinical care. She has focused her clinical research on antibody-mediated rejection in liver transplantation and acute-on-chronic liver failure (ACLF) and is currently the Chief of Hepatology at the Dallas VA Medical Center.
- 1.00 AMA